Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4621 Cb
2. Mobiforton
3. Mtw-tetrazepam
4. Musapam
5. Musaril
6. Myolastan
7. Myospasmal
8. Panos
9. Rilex
10. Tethexal
11. Tetra-saar
12. Tetramdura
13. Tetrarelax
14. Tetrazep 1a Pharma
15. Tetrazep Abz
16. Tetrazep Von Ct
1. Myolastan
2. Musaril
3. Clinoxan
4. 10379-14-3
5. Cb 4261
6. Ro 06-6657
7. 4261 Cb
8. 7-chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-one
9. 2h-1,4-benzodiazepin-2-one, 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-
10. Fo92091vp8
11. Tetrazepam (inn)
12. 7-chloro-5-(1-cyclohexenyl)-1-methyl-2-oxo-2,3-dihydro-1h-(1,4)-benzo(f)diazepine
13. Cb-4261
14. Tetrazepam [inn]
15. 7-chloro-5-(cyclohexen-1-yl)-1-methyl-3h-1,4-benzodiazepin-2-one
16. Tetrazepamum
17. Tetrazepamum [inn-latin]
18. Tetrazepam [inn:ban:dcf]
19. Einecs 233-837-7
20. Brn 0890548
21. Unii-fo92091vp8
22. Dea No. 2886
23. Myolastan (tn)
24. Tetrazepam [mi]
25. Tetrazepam [mart.]
26. Tetrazepam [who-dd]
27. 5-24-04-00064 (beilstein Handbook Reference)
28. Schembl157998
29. Zinc2144
30. Chembl2105527
31. Dtxsid00146058
32. Tetrazepam [ep Monograph]
33. Chebi:135198
34. Tetrazepam 0.1 Mg/ml In Methanol
35. Cs-6656
36. Db13324
37. 7-chloro-5-(1-cyclohexen-1- Yl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-one
38. Hy-101615
39. D07277
40. Q421104
41. 7-chloro-5-(1-cyclohexen-1-yl)-1-methyl-1,3-dihydro-2h-1,4-benzodiazepin-2-one #
42. 7-chloro-5-(cyclohex-1-en-1-yl)-1-methyl-1,3-dihydro-2h-benzo[e][1,4]diazepin-2-one
43. 7-chloro-5-(cyclohex-1-en-1-yl)-1-methyl-2,3-dihydro-1h-1,4-benzodiazepin-2-one
Molecular Weight | 288.77 g/mol |
---|---|
Molecular Formula | C16H17ClN2O |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 288.1029409 g/mol |
Monoisotopic Mass | 288.1029409 g/mol |
Topological Polar Surface Area | 32.7 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 457 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03B - Muscle relaxants, centrally acting agents
M03BX - Other centrally acting agents
M03BX07 - Tetrazepam
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?